FPipTB, a benzimidazole derivative, induces chondrosarcoma cell apoptosis via endoplasmic reticulum stress and apoptosis signal‐regulating kinase 1
Authors:
- 18 May 2011
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 51 (4) , 315-326
Abstract
Chondrosarcoma is the second most common primary bone tumor and it responds poorly to both chemotherapy and radiation treatment. In this study, we investigated the anticancer effects of a new benzimidazole derivative, 2‐(furanyl)‐5‐(piperidinyl)‐ (3,4,5‐trimethoxybenzyl) benzimidazole (FPipTB) in human chondrosarcoma cells. FPipTB‐induced apoptosis in human chondrosarcoma cell lines (JJ012 and SW1353) but not in primary chondrocytes. Furthermore, it triggered endoplasmic reticulum (ER) stress, which was characterized by changes in cytosolic calcium levels. Treatment of chondrosarcoma cells with FPipTB was associated with increased intracellular levels of ASK1, p38, p53, and Bax, followed by release of cytochrome c from mitochondria and activation of caspases. It is also known that ER stress activates apoptosis signal‐regulating kinase 1 (ASK1), which mediates activation of JNK and p38 pathways. We also found that FPipTB‐induced p38 and p53 phosphorylation and upregulated Bax expression. To study the mechanism of Bax upregulation, we determined that Bax promoter activity was increased in FPipTB‐treated cells, leading to an increase in intracellular levels of Bax. In addition, cell treated with Ca2+ chelator or p38 inhibitor showed reduced transcriptional activity. The results further suggest that FPipTB triggered ER stress, as indicated by changes in cytosolic calcium levels and activated the ASK1‐MKK3/6‐p38‐p53‐Bax pathway, causing chondrosarcoma cell death. Importantly, animal studies revealed a dramatic 40% reduction in tumor volume after 21 d of treatment. Thus, FPipTB may be a novel anticancer agent for the treatment of chondrosarcoma.Keywords
This publication has 53 references indexed in Scilit:
- Targeting ASK1 in ER stress-related neurodegenerative diseasesExpert Opinion on Therapeutic Targets, 2009
- Integrated Endoplasmic Reticulum Stress Responses in CancerCancer Research, 2007
- Endoplasmic reticulum stress exacerbates ischemia‐reperfusion‐induced apoptosis through attenuation of Akt protein synthesis in human choriocarcinoma cellsThe FASEB Journal, 2006
- The Unfolded Protein Response: A Novel Component of the Hypoxic Stress Response in TumorsMolecular Cancer Research, 2005
- RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasionJournal of Orthopaedic Research, 2005
- Involvement of ASK1 in Ca2+‐induced p38 MAP kinase activationEMBO Reports, 2004
- ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeatsGenes & Development, 2002
- Physiological Roles of ASK1-Mediated Signal Transduction in Oxidative Stress- and Endoplasmic Reticulum Stress-Induced Apoptosis: Advanced Findings from ASK1 Knockout MiceAntioxidants & Redox Signaling, 2002
- Sustained ER Ca2+ Depletion Suppresses Protein Synthesis and Induces Activation-enhanced Cell Death in Mast CellsJournal of Biological Chemistry, 2002
- Chemotherapy and P‐glycoprotein expression in chondrosarcomaJournal of Orthopaedic Research, 1998